Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

This study has been terminated.
(Slow accrual)
Sponsor:
Collaborator:
Ortho Biotech, Inc.
Information provided by:
University of Kentucky
ClinicalTrials.gov Identifier:
NCT00176293
First received: September 13, 2005
Last updated: April 20, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2007
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)